evaluation of acute hematologic and long-term pulmonary toxicities of radioimmunotherapy of cryptococcus neoformans infection in murine models
in vitro activity of daptomycin against gram-positive european clinical isolates with defined resistance determinants
in vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections
quantitative analysis of a parasitic antiviral strategy
ribosomal mutations in arcanobacterium pyogenes confer a unique spectrum of macrolide resistance
staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group i or ii
role of attp in integrase-mediated integration of the shigella resistance locus pathogenicity island of shigella flexneri
in vitro evolution predicts that the imp-1 metallo-ß-lactamase does not have the potential to evolve increased activity against imipenem
in vitro activities of tigecycline against the bacteroides fragilis group
in vitro activities of new quinolones and oxazolidinones against actinomadura madurae
selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an enterobacter aerogenes clinical isolate
inhibitors of antibiotic efflux in resistant enterobacter aerogenes and klebsiella pneumoniae strains
comparative efficacies of four amphotericin b formulations-fungizone, amphotec (amphocil), ambisome, and abelcet-against systemic murine aspergillosis
relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers
synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against klebsiella pneumoniae, enterobacter cloacae, and acinetobacter baum..
inhibition of ß-lactamase ii of bacillus cereus by penamaldic derivatives of penicillins
activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to staphylococcus aureus with or without reduced susceptibility to vancomy..
resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded ampc ß-lactamase of a serratia marcescens clinical isolate
a second tylosin resistance determinant, erm b, in arcanobacterium pyogenes
mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria
comparative in vitro activities of ac98-6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin, and other antimicrobial agents a..
antibiotic susceptibility of tropheryma whipplei in mrc5 cells
in vitro double and triple synergistic activities of polymyxin b, imipenem, and rifampin against multidrug-resistant acinetobacter baumannii
activity of posaconazole combined with amphotericin b against aspergillus flavus infection in mice: comparative studies in two laboratories
activities of garenoxacin against quinolone-resistant streptococcus pneumoniae strains in vitro and in a mouse pneumonia model
quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms
early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study
effect of zinc salts on respiratory syncytial virus replication
preclinical pharmacology and pharmacokinetics of gw433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir
new findings on the structure-phototoxicity relationship and photostability of fluoroquinolones with various substituents at position
pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men
possible involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein mrp2 in disposition of azithromycin
disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma
quality assurance program for clinical measurement of antiretrovirals: aids clinical trials group proficiency testing program for pediatric and adult pharmacology l..
in vitro and in vivo activities of antimicrobials against nocardia brasiliensis
isolation and characterization of integron-containing bacteria without antibiotic selection
selection of an antibiotic-hypersusceptible mutant of pseudomonas aeruginosa : identification of the glmr transcriptional regulator
miltefosine induces apoptosis-like death in leishmania donovani promastigotes
effect of antibiotic treatment delay on therapeutic outcome of experimental acute otitis media caused by streptococcus pneumoniae strains with different susceptibil..
geldanamycin, a ligand of heat shock protein 90, inhibits the replication of herpes simplex virus type 1 in vitro
in vitro activities of 3-(halogenated phenyl)-5-acyloxymethyl- 2,5-dihydrofuran-2-ones against common and emerging yeasts and molds
plasmodium falciparum isolates in india exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance
killing by ampicillin and ofloxacin induces overlapping changes in escherichia coli transcription profile
fluorescence detection-based functional assay for high-throughput screening for mray
tetracycline and streptomycin resistance genes, transposons, and plasmids in salmonella enterica isolates from animals in italy
novel chromosomally encoded multidrug efflux transporter mdea in staphylococcus aureus
pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjects
quercetin induces apoptosis of trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages
two sets of paralogous genes encode the enzymes involved in the early stages of clavulanic acid and clavam metabolite biosynthesis in streptomyces clavuligerus
tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers
activities of ciprofloxacin and moxifloxacin against stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic ..
plasmodium falciparum -based bioassay for measurement of artemisinin derivatives in plasma or serum
interactions between penicillin-binding proteins (pbps) and two novel classes of pbp inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones
in vitro evaluation of double and triple combinations of antifungal drugs against aspergillus fumigatus and aspergillus terreus
intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy
amphotericin b and fluconazole, a potent combination therapy for cryptococcal meningitis
molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69..